SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer remains at the center of investor frustration as the stock struggles with volatility and ongoing community debates over alleged management controversies, chip smuggling probes, and the impact of capital raising activities. Despite these concerns, bullish investors continue to highlight a massive order backlog and long-term AI infrastructure demand as catalysts for a potential rebound.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently the focal point of intense market speculation as retail investors debate the stock's valuation ahead of upcoming vehicle delivery reports and long-term autonomy narratives. While the community remains deeply divided, active discussions center on the stock's recent price volatility, the potential for a gamma squeeze, and the influence of Elon Musk's various ventures on institutional sentiment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors speculate on a potential buyout and upcoming phase 3 clinical trial data, creating a high-pressure environment for short sellers. The community is actively tracking record-breaking options volume and tight borrow supply, with many bullish participants holding for long-term catalysts despite the rapid price appreciation.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is capturing significant community attention as it positions itself as a scalable layer-one blockchain, with investors highlighting its speed, low fees, and growing utility in tokenized equities and stablecoin remittances. The conversation is currently driven by active staking strategies and bullish outlooks on its long-term potential as a high-performance alternative to Ethereum, despite ongoing market volatility.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is drawing significant attention as investors re-price its exposure to the growing Physical AI and robotics sectors, bolstered by the launch of its REV8 native color lidar and new strategic manufacturing agreements. Community discourse is heavily focused on the stock's potential for long-term growth as an essential infrastructure player in automation, with many participants debating the stock's recent volatility versus its fundamental potential as a foundational sensing technology.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community prepares for the upcoming FDA Advisory Committee meeting in late July, which is being viewed as a critical step toward validating the company's dual-indication efficacy data. Investors are actively debating the impact of ongoing litigation with Nippon Shinyaku while maintaining high conviction in the potential for a broad label approval and a subsequent share price revaluation.

Charter Communications, Inc. engages in providing broadband communications services. Its services include Spectrum TV, Spectrum Internet, and Spectrum Voice. It offers business-to-business Internet access, data networking, business telephone, video and music entertainment services, and wireless backhaul. Its advertising sales division, Spectrum Reach, offers local, regional, and national businesses the opportunity to advertise in individual and multiple service areas on cable television networks and advanced advertising platforms. The company was founded in 1993 and is headquartered in Stamford, CT.

Charter Communications Inc. - Ordinary Shares - Class A

Charter Communications is seeing significant volatility and intense short-selling activity as investors react to a combination of heavy institutional outflows from recent index rebalancing and ongoing market skepticism toward the broadband sector. The community is deeply divided, with many traders betting on a massive short squeeze driven by the company's aggressive stock buybacks and low valuation multiples, while skeptics point to mounting debt concerns and stiff competition as reasons for the continued bearish trend.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing significant market momentum driven by reports of a major satellite connectivity contract win in Japan and successful deployment of its latest satellite constellation. Community sentiment remains highly bullish, with many investors anticipating a significant short squeeze as they closely monitor progress on operational milestones and upcoming commercial partnerships.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing strong momentum as the market digests recent earnings and reprices the company based on QNX growth, fiscal outlook upgrades, and its evolving role in the physical AI and automotive software sectors. The community is actively discussing a perceived 're-rating' of the stock, with long-term shareholders celebrating the sustained move higher while debating the potential for an epic short squeeze.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing a wave of negative sentiment as analysts downgrade the stock ahead of earnings, while the community remains sharply divided between those calling it a generational value opportunity and others labeling it a broken brand. Investors are closely debating the potential impact of tariff refunds and international growth, even as technical signals indicate significant downward pressure and structural fatigue.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead, Merck, Eli Lilly Lead $106B Biopharma Takeover Wave In 2026

Equity

Biopharma M&A has surged to $106 billion across 201 deals through early June 2026, putting the sector on track for its strongest full-year total since the 2019 pre-pandemic peak, CNBC reported.

Best Medical Stocks To Follow Now - May 3rd

Eli Lilly and Company, UnitedHealth Group, and Arcellx are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, or deliver medical products and servicessuch as pharmaceuticals, biot...

Mid Cap Stocks To Keep An Eye On - May 2nd

ProShares UltraPro Short QQQ, AXT, Arcellx, Direxion Daily TSLA Bull 2X Shares, and AltC Acquisition are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap...

Medical Stocks Worth Watching - May 2nd

Eli Lilly and Company, UnitedHealth Group, Arcellx, Johnson & Johnson, and Merck & Co., Inc. are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks...

Promising Mid Cap Stocks To Consider - May 1st

ProShares UltraPro Short QQQ, Arcellx, AXT, Direxion Daily TSLA Bull 2X Shares, AltC Acquisition, USA Rare Earth, and SoundHound AI are the seven Mid Cap stocks to watch today, according to...

Promising Medical Stocks To Watch Now - May 1st

Eli Lilly and Company, Arcellx, Veeva Systems, Novo Nordisk A/S, and UnitedHealth Group are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are...

Pictet Asset Management Holding SA Decreases Stake in Arcellx, Inc. $ACLX

Pictet Asset Management Holding SA lessened its holdings in shares of Arcellx, Inc. (NASDAQ:ACLX - Free Report) by 18.6% during the 4th quarter, according to the company in its most recent 13F filing...

Mid Cap Stocks Worth Watching - April 30th

ProShares UltraPro Short QQQ, Arcellx, Marathon Digital, Direxion Daily TSLA Bull 2X Shares, and TeraWulf are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener tool...

Best Value Stocks To Follow Now - April 30th

Invesco QQQ, Intel, Sandisk, Bloom Energy, ProShares UltraPro Short QQQ, CoreWeave, and Arcellx are the seven Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks...

Best Medical Stocks To Keep An Eye On - April 30th

Eli Lilly and Company, Arcellx, UnitedHealth Group, AbbVie, and Novo Nordisk A/S are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. "Medical stocks" are shares...

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.

Arcellx Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ACLXArcellx Inc

Fundamentals

Latest ACLX News